Overview

A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This open-label study examines the efficacy and safety of albiglutide as compared with liraglutide in subjects with type 2 diabetes.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Glucagon-Like Peptide 1
Liraglutide
rGLP-1 protein